CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats

Journal of the American Society of Nephrology

Volumn 9, Issue 4, 1998, Pages 590-597

  Nangaku, Masaomi ^a   Alpers, Charles E ^b   Pippin, Jeffrey ^b   Shankland, Stuart J ^b   Kurokawa, Kiyoshi ^d   Adler, Stephen ^c   Morgan, B Paul ^e   Johnson, Richard J ^b   Couser, William G ^b,f  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d TOKAI UNIVERSITY   (Japan)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRIN DEPOSITION; GLOMERULONEPHRITIS; GLOMERULUS; IMMUNOMODULATION; INFLAMMATORY CELL; KIDNEY DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION;

EID: 0031900114     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Couser WG: The pathogenesis of glomerulonephritis. Kidney Int 44: S19-S26, 1993
2. Hebert LA, Cosio FG, Birmingham DJ: The role of complement system in renal injury. Semin Nephrol 12: 408-427, 1992
3. Couser WG, Schulze M, Pruchno CJ: Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant 7: S25-S31, 1992
4. Groggel GC, Adler S, Rennke HG, Couser WG: Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest 72: 1948-1957, 1983
5. Salant DJ, Quigg RJ, Cybulsky AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 35: 976-984, 1989
6. Savin VJ, Johnson RJ, Couser WG: C5b-9 increases albumin permeability of isolated glomeruli in vitro. Kidney Int 46: 382-387, 1994
7. Brandt J, Pippin J, Schulze M, Hänsch GM, Alpers CE, Johnson RJ, Gordon K, Couser WG: Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49: 335-343, 1996
8. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Johnson RJ, Couser WG: Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int 52: 1570-1578, 1998
9. Morgan BP, Meri S: Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 15: 369-396, 1994
10. Rollins SA, Sims PJ: The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 144: 3478-3483, 1990
11. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ: Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalyzed insertion of C9 into lipid bilayers. Immunology 71: 1-9, 1990
12. Hughes TR, Meri S, Davies M, Williams JD, Morgan BP: Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells. Immunology 80: 439-444, 1993
13. Quigg RJ, Morgan BP, Holers VM, Adler S, Sneed AE III, Lo CF: Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int 48: 412-421, 1995
14. Quigg RJ, Holers VM, Morgan BP, Sneed AE III: Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J Immunol 154: 3437-3443, 1995
15. Nangaku M, Meek RL, Pippin J, Gordon KL, Morgan BP, Johnson RJ, Couser WG: Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int 50: 257-266, 1996
16. Matsuo S, Nishikage H, Yoshida F, Nomura A, Piddlesden SJ, Morgan BP: Role of CD59 in experimental glomerulonephritis in rats. Kidney Int 46: 191-200, 1994
17. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Couser WG, Johnson RJ: A new model of renal microvascular endothelial injury. Kidney Int 52: 182-194, 1997
18. Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG: Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int 50: 2054-2062, 1996
19. Mariani M, Camagna M, Tarditi L, Secamani E: A new enzymatic method to obtain high-yield F(ab)2 suitable for clinical use from mouse IgG1. Mol Immunol 28: 69-77, 1991
20. Hughes TR, Piddlesden SJ, Williams JD, Harrison RA, Morgan BP: Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J 284: 169-176, 1992
21. Bagchus WM, Jeunink MF, Rozing J, Elema JD: A monoclonal antibody against rat platelets. I. Tissue distribution in vitro and in vivo. Clin Exp Immunol 75: 317-323, 1989
22. Duijvestijn AM, van Goor H, Klatter F, Majoor GD, van Bussel E, van Breda Vriesman PJC: Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66: 459-466, 1992
23. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35: 60-68, 1989
24. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ: Pathogenesis of cyclosporine nephropathy: roles of Angiotensin II and osteopontin. J Am Soc Nephrol 6: 1186-1196, 1995
25. Hugo C, Hugo C, Pichler R, Gordon K, Schmidt R, Amieva M, Couser WG, Furthmayr H, Johnson RJ: The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor, in experimental mesangial proliferative glomeruionephritis. J Clin Invest 97: 2499-2508, 1996
26. Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG: Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 142: 179-187, 1993
27. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77: 762-767, 1986
28. Hänsch GM, Schieren G, Wagner C, Schönermark M: Immune damage to the mesangium: Antibody- and complement-mediated stimulation and destruction of mesangial cells. J Am Soc Nephrol 2: S139-S143, 1992
29. Nangaku M, Johnson RJ, Couser WG: Glomerulonephritis and complement regulatory proteins. Exp Nephrol 5: 345-354, 1997
30. Davies SJ, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H: CD59: An Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170: 637-654, 1989
31. Holguin MH, Fredrick LR, Bernshaw NJ, Wilcox LA, Parker CJ: Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84: 7-17, 1989
32. Okada N, Harada R, Fujita T, Okada H: A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1: 205-208, 1989
33. Sugita Y, Nakano Y, Tomita M: Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J Biochem 104: 633-637, 1988
34. Tamai H, Matsuo S, Fukatsu A, Nishikawa K, Sakamoto N, Yoshioka K, Okada N, Okada H: Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli: An immunofluorescence study. Clin Exp Immunol 84: 256-262, 1991
35. Meri S, Waldmann H, Lachmann PJ: Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65: 532-537, 1991
36. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S: Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 46: 89-96, 1994
37. Shibata T, Kohsaka T: Effects of complement activation on the expression of CD59 by human mesangial cells. J Immunol 155: 403-409, 1995
38. Yuzawa Y, Brett J, Fukatsu A, Matsuo S, Caldwell PR, Niesen N, Milgrom F, Godman G, Stern D, Andres G: Interaction of antibody with Forssman antigen in guinea pigs: A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol 146: 1260-1272, 1995
39. Yuzawa Y, Brentjens JR, Brett J, Caldwell PR, Esposito C, Fukatsu A, Godman G, Stern D, Andres G: Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. J Immunol 150: 5633-5646, 1993
40. Li B, Sallee C, Dehoff M, Foley S, Molina H, Holers VM: Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of functional homologue of human MCP and DAF. J Immunol 151: 4295-4305, 1993
41. Oglesby TJ, Allen CJ, Liszewski MK, White DJG, Atkinson JP: Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 175: 1547-1551, 1992
42. Nicholson-Weller A, Wang C: Structure and function of decay accelerating factor CD55. J Lab Clin Med 123: 485-491, 1994
43. Kim Y, Kinoshita T, Molina H, Hourcade D, Seya T, Magner LM, Holers VM: Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181: 151-159, 1995
44. Wagner C, Braunger M, Beer M, Rother K, Hänsch GM: Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 2: 51-56, 1994
45. Platt JL: A perspective on xenograft rejection and accommodation. Immunol Rev 141: 127-149, 1994
46. Sims PJ, Wiedmer T: Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin Cell Biol 6: 275-282, 1995
47. Hattori R, Hamilton KK, McEver RP, Sims PJ: Complement protein C5b-9 induces secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264: 9053-9060, 1989
48. Hamilton KK, Hattori R, Esmon CT, Sims PJ: Complement protein C5b-9 induces vesiculation of the endothelial plasma membrane and exposes catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265: 3809-3814, 1990
49. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182: 1807-1814, 1995
50. Platt JL, Vercellotti GM, Lindman BJ, Oegema TR Jr, Back FH, Dalmasso AP: Release of heparan sulfate from endothelial cells. J Exp Med 171: 1363-1368, 1990
51. Saadi S, Platt JL: Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 171: 1363-1368, 1995
52. Hamilton KK, Ji Z, Rollins S, Stewart BH, Sims PJ: Regulatory control of the terminal complement proteins at the surface of human endothelial cells: Neutralization of a C5b-9 inhibitor by antibody to CD59. Blood 76: 2572-2577, 1990
53. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS: Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 155: 1434-1441, 1995
54. Robson SC, Candinas D, Hancock WW, Wrighton C, Winkler H, Bach FH: Role of endothelial cells in transplantation. Int Arch Allergy Immunol 106: 305-322, 1995
55. Platt JL: The immunological barriers to xenotransplantation. Crit Rev Immunol 16: 331-358, 1996
56. Fryer JP, Leventhal JR, Matas AJ: The emergence of xenotransplantation. Transplant Immunol 3: 21-31, 1995